Zugriffe | |
---|---|
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 206 |
Oktober 2023 | November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 1 | 1 | 0 | 1 | 7 | 3 | 0 |
Zugriffe | |
---|---|
art_3A10.1186_2Fs13195-016-0189-7.pdf | 161 |